FIELD: chemistry.
SUBSTANCE: invention relates to N-carb(arginyl)oxymethylimidazo[4,5-e]benzo[1,2-c; 3,4-c']difuroxane of formula .
EFFECT: improved properties of the compound.
1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
THROMBOCYTE AGGREGATION-INHIBITING N-CARB(GLUTAMINYL)OXYMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2012 |
|
RU2502739C9 |
THROMBOCYTE AGGREGATION-INHIBITING HETEROMERIC PEPTIDES BASED ON IMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2550223C1 |
N-CARBOXYMETHYLIMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2544547C1 |
METHOD FOR PRODUCTION OF N-CARBETHOXYMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2017 |
|
RU2663846C1 |
METHOD FOR PRODUCING N-CARBETOXIMETHYLIMIDEAZO[4,5-e]BENZO[1,2-c;3,4-c']DYFUROXANE | 2016 |
|
RU2618230C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
RGD-LIKE PEPTIDES | 2009 |
|
RU2396271C1 |
METHOD OF PRODUCING N-ALLYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2019 |
|
RU2718905C1 |
METHOD OF PRODUCING N-CYANOMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2019 |
|
RU2707296C1 |
METHOD OF PRODUCING N-CARBETHOXYMETHYL-C-METHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2020 |
|
RU2725631C1 |
Authors
Dates
2015-04-27—Published
2014-02-17—Filed